(Q77647580)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

toxic epidermal necrolysis

1 reference

P Wolkenstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J Latarjet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J C Roujeau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Duguet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S Boudeau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

L Vaillant

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Maignan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M H Schuhmacher

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

B Milpied

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A Pilorget

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

H Bocquet

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Brun-Buisson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J Revuz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1586-1589

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

9140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

Severe adverse cutaneous reactions to drugs

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy"

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Plasmapheresis in severe drug-induced toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Toxic epidermal necrolysis treated with cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

A simplified acute physiology score for ICU patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Evolving pattern of drug-induced toxic epidermal necrolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Exact logistic regression: theory and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

Enhancement of phorbol ester-induced production of tumor necrosis factor alpha by thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902197-7

7 January 2021

10.1016/S0140-6736(98)02197-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9843104%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference